Novartis will add a new North Carolina facility for active pharmaceutical ingredient (API) manufacturing for solid dosage ...
Opportunities in the pharmaceutical API manufacturing market include leveraging rising demand for complex biologics, ...
Key market opportunities in the CDMO for formulations sector include increasing demand for custom peptide synthesis, ...
Novartis will construct an active pharmaceutical ingredient (API) facility in Morrisville, North Carolina, the company said ...
LONGMONT, Colo.--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, ...
QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...
DUBLIN, May 10, 2021 /PRNewswire/ -- The "Global Active Pharmaceutical Ingredient Market (2020-2025) by Type, Molecule, Product Type, Formulation Type, Manufacturing Type, Synthesis Type, Drug Type, ...
India hosts more active pharmaceutical ingredient (API) manufacturing sites that are compliant with the U.S. Food and Drug Administration than any country outside the U.S., and it produces more ...
Novartis announces a new API facility in Morrisville, NC, as part of its $23bn US manufacturing expansion, boosting biopharma ...
India, May 2 -- A pharma-chemical stock is drawing attention as a long-stagnant manufacturing business looks to enter a stronger growth phase through new API expansion plans. The company has built ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results